Study Of Use Of Pashanbhedadi Ghanvati In The Treatment Of Enlargement Of Prostate.

"RANDOMIZED CONTROLLED CLINICAL TRIAL OF EFFICACY OF PASHANBHEDADI GHANVATI IN THE MANAGEMENT OF VAATASHTHILA W.S.R. TO BENIGN PROSTATE HYPERPLASIA"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029083

Enrollment

Registered

2020-11-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: PASHANBHEDADI GHANVATI: Pashanbhedadi Ghanvati 1gm BD giveng to the patient with normal water before meals for 45 days and assessment done on 15th 30th and 45th day Control Intervention

Eligibility

Inclusion criteria

Inclusion criteria: Patients having prostate size 30 to 100 gram Patients having post void residual volume 50 to 200 ml Patients willing to participate in study Patients having mild 1 to 7 moderate 8 to 19 international prostate symptom score Patients with severe 20 to 35 international prostate symptom score with no other consequences of benign prostate Hyperplasia and reluctant for surgery

Exclusion criteria

Exclusion criteria: Patients of malignant prostatic enlargement or prostatitis or uremia septicemia or renal failure Patients having other urological pathologies like nephrotic syndrome or glomerulo nephritis or chronic kidney diseases etc Increased serum creatinine and blood urea Patients having HIV or HBsAg or major systemic disorders like uncontrolled HTN or DM or PTB etc Patients participating in other clinical trials Patients having hematuria Patients with acute urine retention which needs surgical intervention Patients currently using any other form of medicle therapy for benign prostate hyperplasia

Design outcomes

Primary

Measure	Time frame
To find out how Pashanbhedadi Ghanvati reduces the prostate size and post void residual volumeTimepoint: 45 days	—

Secondary

Measure	Time frame
To establish the better medicinal alternative in the management of Vaatashthila To find out effects of Pashanbhedadi Ghanvati on the other symptoms of VaatashthilaTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr R H Amilkanthawar

Government Ayurved College And Hospital Nanded

drarajendrah@gmail.com9890569621

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026